Deepen Patel

Fel d 1–derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: A randomized, placebo-controlled study

Deepen Patel, Peter Couroux, Pascal Hickey et al. · Journal of Allergy and Clinical Immunology · 2012 · 199 citations · Full text

Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial

Gary T. Ferguson, J. Mark FitzGerald, Eugene R. Bleecker et al. · The Lancet Respiratory Medicine · 2017 · 121 citations

Asthma, Rheumatology, Allergy Medicine +7

Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: Olopatadine hydrochloride versus mometasone furoate monohydrate

Deepen Patel, Rekha Garadi, Michael Brubaker et al. · Allergy and Asthma Proceedings · 2007 · 65 citations

Asthma, Drug Hypersensitivity, Rapid Relief +15

Solubilized nasal steroid (CDX-947) when combined in the same solution nasal spray with an antihistamine (CDX-313) provides improved, fast-acting symptom relief in patients with allergic rhinitis

Anne Marie Salapatek, Joanne Lee, Deepen Patel et al. · Allergy and Asthma Proceedings · 2011 · 37 citations

Asthma, Environmental Allergy, Allergy Medicine +17

Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge

Jonathan Corren, Robert A. Wood, Deepen Patel et al. · Journal of Allergy and Clinical Immunology · 2011 · 37 citations

Asthma, Allergy, Pulmonary Function +8